Europe Drug Delivery Systems Market to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others) and Geography
- THE3216985
- 235 Pages
- June 2019
- Medical Devices
Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions in Europe is expected to foster the growth of the Europe drug delivery systems market. On the other hand, regulatory recalls for drug delivery systems by European manufacturers are likely to create a negative impact on the market growth to an extent. However, the development of drug delivery devices to cater to the increasing infectious disease incidence in Europe is expected to offer growth opportunities for market players in the region over the course of years.
Europe has a huge pool of patient population suffering from various chronic disease conditions. Europe is highly affected by non-communicable diseases that include cardiovascular diseases, diabetes, cancer, mental disorders, and chronic respiratory diseases. According to the World Health Organization (WHO) 2016, these five major diseases collectively account for 77% of the total disease burden in the European region. WHO Europe states that approximately 17 million people across the globe due to cardiovascular diseases. According to the European Heart Network (EHN), cardiovascular diseases account for 45% of deaths in Europe and 37% deaths in the European Union. In addition, diseases of respiratory systems are also one of the main factors contributing to the European disease burden. This disease majorly deals with the oral passage, nasal cavity, larynx, pharynx, trachea, and bronchitis. According to Europa, the statistical portal, the standardized death rate in Europe due to chronic respiratory diseases was recorded to be 88.4 deaths per 100,000 populations in 2015. Furthermore, diabetes being one of the leading global factors for mortality also significantly affect death rates in Europe. According to the World Health Organization (WHO), about 60 million patients in Europe suffer due to diabetes, of which majority of patients have obesity, physical inactivity, and unhealthy diets as prime reasons for the cause of the disease. Owing to a high prevalence of chronic diseases across the European region, the market for drug delivery systems is expected to witness a rising growth o over the coming years.
The drug delivery systems market on the basis of route of administration is majorly classified into oral, transmucosal, injectable, topical, implantable, and ocular. In 2018, the oral segment held the largest market share of 50.2% of the drug delivery systems market, by route of administration. The oral segment is expected to dominate its market share in 2027 owing to ease of drug administration, a high degree of flexibility on dosages, and cost-effectiveness. Moreover, the oral segment is expected to be the most preferred type of route of administration.
Some of the major primary and secondary sources for drug delivery systems included in the report are European Heart Network (EHN), Food and Drug Administration (FDA), World Health Organization, European Health Management Association (EHMA), European Medicines Agency (EMA) and others.
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Europe Drug Delivery Systems Market – Key Takeaways
3. Europe Drug Delivery Systems Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Drug Delivery Systems Market – By Route of Administration
3.2.2 Europe Drug Delivery Systems Market – By Application
3.2.3 Europe Drug Delivery Systems Market – By Distribution Channel
3.2.4 Europe Drug Delivery Systems Market – By Country
3.3 PEST Analysis
4. Europe Drug Delivery Systems Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Investments by Pharmaceutical and Medical Device Companies in R&D
4.1.2 Rise of Chronic Disease Conditions in Europe
4.2 Key Market Restraints
4.2.1 Recent Product Recalls for Drug Delivery Systems in Europe
4.3 Key Market Opportunities
4.3.1 Growing Prevalence of Infectious Diseases
4.4 Future Trends
4.4.1 New Drug Delivery Systems In Development
4.5 Impact Analysis
5. Drug Delivery Systems Market – Europe Analysis
5.1 Europe Drug Delivery Systems Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
6. Europe Drug Delivery Systems Market Analysis – By Route Of Administration
6.1 Overview
6.2 Europe Drug Delivery Systems Market, By Route of Administration, 2018 & 2027 (%)
6.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
6.4 Oral Drug Delivery Market
6.4.1 Overview
6.4.2 Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.4.3 Solid Oral Drugs Market
6.4.3.1 Overview
6.4.3.2 Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Liquid Oral Drugs Market
6.4.4.1 Overview
6.4.4.2 Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Semi-Solid Oral Drugs Market
6.4.5.1 Overview
6.4.5.2 Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Transmucosal Drug Delivery Market
6.5.1 Overview
6.5.2 Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Pulmonary Drug Delivery Market
6.5.3.1 Overview
6.5.3.2 Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3.3 In-metered Dose Inhalers Market
6.5.3.3.1 Overview
6.5.3.3.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3.4 Dry Powder Inhalers Market
6.5.3.4.1 Overview
6.5.3.4.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3.5 Nebulizers Market
6.5.3.5.1 Overview
6.5.3.5.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Nasal Drug Delivery Market
6.5.4.1 Overview
6.5.4.2 Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4.3 Nasal Spray Market
6.5.4.3.1 Overview
6.5.4.3.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4.4 Nasal Drops Market
6.5.4.4.1 Overview
6.5.4.4.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4.5 Nasal Gel Market
6.5.4.5.1 Overview
6.5.4.5.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Buccal Drug Delivery Market
6.5.5.1 Overview
6.5.5.2 Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Sublingual Drug Delivery Market
6.5.6.1 Overview
6.5.6.2 Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.7 Rectal Transmucosal Drug Delivery Market
6.5.7.1 Overview
6.5.7.2 Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.5.8 Vaginal Transmucosal Drug Delivery Market
6.5.8.1 Overview
6.5.8.2 Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Topical Drug Delivery Market
6.6.1 Overview
6.6.2 Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.6.3 Semi-solid Topical Drug Delivery Formulations Market
6.6.3.1 Overview
6.6.3.2 Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
6.6.4 Liquid Topical Drug Delivery Formulations Market
6.6.4.1 Overview
6.6.4.2 Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
6.6.5 Solid Topical Drug Delivery Formulations Market
6.6.5.1 Overview
6.6.5.2 Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
6.6.6 Transdermal Patches Market
6.6.6.1 Overview
6.6.6.2 Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)
6.6.7 Transdermal Gels Market
6.6.7.1 Overview
6.6.7.2 Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)
6.6.8 Others Market
6.6.8.1 Overview
6.6.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
6.7 Injectable Drug Delivery Market
6.7.1 Overview
6.7.2 Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.7.3 Conventional Injection Devices Market
6.7.3.1 Overview
6.7.3.2 Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4 Self-Injection Devices Market
6.7.4.1 Overview
6.7.4.2 SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4.3 Needle Free Injectors Market
6.7.4.3.1 Overview
6.7.4.3.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4.4 Pen injectors Market
6.7.4.4.1 Overview
6.7.4.4.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.7.4.5 Wearable Injectors Market
6.7.4.5.1 Overview
6.7.4.5.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Implantable Drug Delivery Market
6.8.1 Overview
6.8.2 Implantable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.8.3 Active Implantable Market
6.8.3.1 Overview
6.8.3.2 Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)
6.8.4 Passive Implantable Market
6.8.4.1 Overview
6.8.4.2 Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)
6.9 Ocular Drug Delivery Market
6.9.1 Overview
6.9.2 Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
6.9.3 Eye Drops and Sprays Market
6.9.3.1 Overview
6.9.3.2 Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)
6.9.4 Gels & Ointments Market
6.9.4.1 Overview
6.9.4.2 Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)
6.9.5 Ocular Inserts Market
6.9.5.1 Overview
6.9.5.2 Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)
6.9.6 Drug Coated Contact Lens Market
6.9.6.1 Overview
6.9.6.2 Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)
7. Europe Drug Delivery Systems Market Analysis – By Application
7.1 Overview
7.2 Europe Drug Delivery Systems Market, By Application, 2018 & 2027 (%)
7.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
7.4 Homecare Settings Market
7.4.1 Overview
7.4.2 Europe Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Hospitals & Clinics Market
7.5.1 Overview
7.5.2 Europe Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others Market
7.6.1 Overview
7.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Drug Delivery Systems Market Analysis – By Distribution Channel
8.1 Overview
8.2 Europe Drug Delivery Systems Market, By Distribution Channel, 2018 & 2027 (%)
8.3 Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
8.4 Hospital Pharmacies Market
8.4.1 Overview
8.4.2 Europe Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Retail Pharmacies Market
8.5.1 Overview
8.5.2 Europe Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Online Pharmacies Market
8.6.1 Overview
8.6.2 Europe Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027
9.1.1 Overview
9.1.2 Europe Drug Delivery Systems Market revenue Overview, by Country (2017) (US$ Mn)
9.1.3 Europe Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.4 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
9.1.4.1 Europe Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.2 Europe oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.3 Europe Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.4 Europe Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.5 Europe Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.6 Europe Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.7 Europe Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.8 Europe Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.4.9 Europe Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.5 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6 Europe Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.7 Europe Drug Delivery Systems Market Revenue and Forecasts to 2027, By Country (%)
9.1.8 Germany Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9 Germany Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
9.1.9.1.1 Germany Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.2 Germany Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.3 Germany Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.4 Germany Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.4.1 Germany Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.5 Germany Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.6 Germany Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.7 Germany Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.1.8 Germany Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.2 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.9.3 Germany Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.10 France Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11 France Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11.1 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
9.1.11.1.1 France Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.2 France Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.3 France Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.4 France Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.5 France Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.6 France Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.7 France Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.8 France Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.1.9 France Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.2 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.11.3 France Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.12 UK Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.13 UK Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.13.1 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
9.1.13.1.1 UK Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.2 UK Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.3 UK Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.4 UK Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.5 UK Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.6 UK Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.7 UK Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.8 UK Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.1.9 UK Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.2 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.13.3 UK Drug Delivery Systems Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10. Drug Delivery Systems Market – Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done by the Companies in the Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Drug Delivery Systems Market–Key Company Profiles
11.1 3M
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 BD
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Boston Scientific Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Novo Nordisk A/S
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bausch Health Companies Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Baxter International, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Boehringer Ingelheim International Gmbh
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Novartis AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 GlaxoSmithKline Plc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Terumo Corporation
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product portfolio
11.10.5 SWOT ANALYSIS
11.10.6 Key Developments
11.11 Johnson & Johnson Services, Inc.
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
Table 2. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 3. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 4. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 5. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 6. Europe Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 7. Europe Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 8. Europe Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 9. Europe Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 10. Europe Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 11. Europe Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 12. Europe Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 13. Europe Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 14. Europe Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 15. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 16. Europe Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 17. Germany Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 18. Germany Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 19. Germany Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 20. Germany Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 21. Germany Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 22. Germany Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 23. Germany Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 24. Germany Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 25. Germany Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 26. Germany Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 27. Germany Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 28. Germany Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 29. France Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route of Administration (US$ Mn)
Table 30. France Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 31. France Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 32. France Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 33. France Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 34. France Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 35. France Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 36. France Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 37. France Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 38. France Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 39. France Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 40. France Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 41. UK Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 42. UK Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 43. UK Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 44. UK Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 45. UK Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 46. UK Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 47. UK Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 48. UK Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 49. UK Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 50. UK Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 51. UK Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 52. UK Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 53. Organic Developments Done By Companies
Table 54. Inorganic Developments Done By Companies
Table 55. Glossary Of Terms, Drug Delivery Systems Market
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
